Latest Insider Transactions at Cigna Corp (CI)
This section provides a real-time view of insider transactions for Cigna Corp (CI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cigna Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cigna Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Donna F Zarcone Director |
BUY
Grant, award, or other acquisition
|
Direct |
226
+0.9%
|
-
|
|
Feb 26
2021
|
William L Roper Director |
BUY
Grant, award, or other acquisition
|
Direct |
226
+2.57%
|
-
|
|
Feb 26
2021
|
Eric C Wiseman Director |
BUY
Grant, award, or other acquisition
|
Direct |
226
+1.14%
|
-
|
|
Feb 26
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Payment of exercise price or tax liability
|
Direct |
17,013
-9.5%
|
$3,572,730
$210.17 P/Share
|
|
Feb 26
2021
|
Timothy C Wentworth CEO Evernorth |
BUY
Grant, award, or other acquisition
|
Direct |
15,670
+19.39%
|
-
|
|
Feb 26
2021
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
523
-3.3%
|
$109,830
$210.31 P/Share
|
|
Feb 26
2021
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,201
+13.02%
|
-
|
|
Feb 26
2021
|
Jason D Sadler Pres., International Health |
BUY
Grant, award, or other acquisition
|
Direct |
3,991
+11.08%
|
-
|
|
Feb 26
2021
|
David Cordani Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,748
-9.76%
|
$4,147,080
$210.31 P/Share
|
|
Feb 26
2021
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,403
+22.41%
|
-
|
|
Feb 26
2021
|
Everett Neville EVP, Solutions & Corp Devt. |
SELL
Payment of exercise price or tax liability
|
Direct |
633
-2.86%
|
$132,930
$210.31 P/Share
|
|
Feb 26
2021
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+11.01%
|
-
|
|
Feb 26
2021
|
Kristen Lauria EVP Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-7.0%
|
$46,200
$210.31 P/Share
|
|
Feb 26
2021
|
Kristen Lauria EVP Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
658
+17.31%
|
-
|
|
Feb 26
2021
|
Noelle K Eder Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
246
-2.58%
|
$51,660
$210.31 P/Share
|
|
Feb 26
2021
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
759
+7.37%
|
-
|
|
Feb 26
2021
|
Matthew G Manders Pres, Government and Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,342
-3.32%
|
$701,820
$210.31 P/Share
|
|
Feb 26
2021
|
Matthew G Manders Pres, Government and Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
5,357
+9.51%
|
-
|
|
Feb 26
2021
|
Brian C Evanko Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,245
-3.06%
|
$261,450
$210.31 P/Share
|
|
Feb 26
2021
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,053
+9.03%
|
-
|
|
Feb 26
2021
|
Nicole S Jones Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,410
-4.13%
|
$716,100
$210.31 P/Share
|
|
Feb 26
2021
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,710
+10.07%
|
-
|
|
Feb 26
2021
|
Steven B Miller EVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,938
-3.21%
|
$616,980
$210.17 P/Share
|
|
Feb 26
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,831
+10.88%
|
-
|
|
Feb 26
2021
|
John M Murabito EVP & Chief Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,466
-1.49%
|
$307,860
$210.31 P/Share
|
|
Feb 26
2021
|
John M Murabito EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,167
+6.0%
|
-
|
|
Feb 26
2021
|
Eric P Palmer Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,587
-4.78%
|
$753,270
$210.31 P/Share
|
|
Feb 26
2021
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,701
+12.96%
|
-
|
|
Feb 26
2021
|
Michael W Triplett Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-2.7%
|
$280,350
$210.31 P/Share
|
|
Feb 26
2021
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,648
+9.57%
|
-
|
|
Feb 24
2021
|
Timothy C Wentworth CEO Evernorth |
BUY
Grant, award, or other acquisition
|
Direct |
7,016
+12.42%
|
-
|
|
Feb 24
2021
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,956
+18.46%
|
-
|
|
Feb 24
2021
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,947
+25.13%
|
-
|
|
Feb 24
2021
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,929
+17.42%
|
-
|
|
Feb 24
2021
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,900
+9.45%
|
-
|
|
Feb 24
2021
|
John M Murabito EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,548
+5.2%
|
-
|
|
Feb 24
2021
|
Kristen Lauria EVP Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,170
+32.01%
|
-
|
|
Feb 24
2021
|
Matthew G Manders Pres, Government and Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
5,219
+10.26%
|
-
|
|
Feb 24
2021
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,034
+15.62%
|
-
|
|
Feb 24
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,287
+4.46%
|
-
|
|
Feb 24
2021
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,690
+10.73%
|
-
|
|
Feb 24
2021
|
Jason D Sadler Pres., International Health |
BUY
Grant, award, or other acquisition
|
Direct |
2,555
+8.35%
|
-
|
|
Feb 24
2021
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Grant, award, or other acquisition
|
Direct |
2,456
+20.0%
|
-
|
|
Feb 24
2021
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
585
+7.89%
|
-
|
|
Feb 11
2021
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+2.83%
|
$132,600
$68.38 P/Share
|
|
Feb 10
2021
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
9,275
-22.74%
|
$1,966,300
$212.32 P/Share
|
|
Feb 10
2021
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,275
+10.13%
|
$630,700
$68.38 P/Share
|
|
Feb 08
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Open market or private sale
|
Indirect |
5,144
-6.27%
|
$1,049,376
$204.86 P/Share
|
|
Feb 04
2021
|
Steven B Miller EVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
622
-2.31%
|
$130,620
$210.53 P/Share
|
|
Feb 04
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Payment of exercise price or tax liability
|
Direct |
4,554
-9.69%
|
$956,340
$210.53 P/Share
|